28320690|t|Use of GetCheckedOnline, a Comprehensive Web-based Testing Service for Sexually Transmitted and Blood-Borne Infections
28320690|a|The British Columbia Centre for Disease Control implemented a comprehensive Web-based testing service GetCheckedOnline (GCO) in September 2014 in Vancouver, Canada. GCO 's objectives are to increase testing for sexually transmitted and blood-borne infections (STBBIs), reach high-prevalence populations facing testing barriers, and increase clinical STI service capacity. GCO was promoted through email invitations to provincial STI clinic clients, access codes to clients unable to access immediate clinic -based testing (deferred testers), and a campaign to gay, bisexual, and other men who have sex with men (MSM). The objective of the study was to report on characteristics of GCO users, use and test outcomes (overall and by promotional strategy) during this pilot phase. We used GCO program data, website metrics, and provincial STI clinic records to describe temporal trends, progression through the service pathway, and demographic, risk, and testing outcomes for individuals creating GCO accounts during the first 15 months of implementation. Of 868 clients creating accounts, 318 (36.6%) submitted specimens, of whom 96 (30.2%) tested more than once and 10 (3.1%) had a positive STI diagnosis. The proportion of clients submitting specimens increased steadily over the course of the pilot phase following introduction of deferred tester codes. Clients were diverse with respect to age, gender, and ethnicity, although youth and individuals of nonwhite ethnicity were underrepresented. Of the 506 clients completing risk assessments, 215 (42.5%) were MSM, 89 (17.6%) were symptomatic, 47 (9.3%) were STI contacts, 232 (45.8%) reported condomless sex, 146 (28.9%) reported â‰¥4 partners in the past 3 months, and 76 (15.0%) reported a recent STI. A total of 63 (12.5%) GCO clients were testing for the first time. For 868 accounts created, 337 (38.8%) were by clinic invitations (0 diagnoses), 298 (34.3%) were by deferred testers (6 diagnoses), 194 (22.4%) were by promotional campaign (3 diagnoses), and 39 (4.5%) were by other means (1 diagnosis). Our evaluation suggests that GCO is an acceptable and feasible approach to engage individuals in testing. Use by first-time testers, repeated use, and STI diagnosis of individuals unable to access immediate clinic -based testing suggest GCO may facilitate uptake of STBBI testing and earlier diagnosis. Use by MSM and individuals reporting sexual risk suggests GCO may reach populations with a higher risk of STI. Motivation to test (eg, unable to access clinical services immediately) appears a key factor underlying GCO use. These findings identify areas for refinement of the testing model, further promotion, and future research (including understanding reasons for drop-off through the service pathway and more comprehensive evaluation of effectiveness). Increased uptake and diagnosis corresponding with expansion of the service within British Columbia will permit future evaluation of this service across varying populations and settings.
28320690	7	23	GetCheckedOnline	T170	C2349146
28320690	27	40	Comprehensive	T080	C1880156
28320690	41	66	Web-based Testing Service	T170	C2349146
28320690	71	91	Sexually Transmitted	T047	C0036916
28320690	96	118	Blood-Borne Infections	T169	C1636665
28320690	123	166	British Columbia Centre for Disease Control	T093	C1708333
28320690	167	178	implemented	T052	C1708476
28320690	181	194	comprehensive	T080	C1880156
28320690	195	220	Web-based testing service	T170	C2349146
28320690	221	237	GetCheckedOnline	T170	C2349146
28320690	239	242	GCO	T170	C2349146
28320690	247	256	September	T079	C3828193
28320690	265	274	Vancouver	UnknownType	C0681784
28320690	276	282	Canada	T083	C0006823
28320690	284	287	GCO	T170	C2349146
28320690	291	301	objectives	T170	C0018017
28320690	309	317	increase	T169	C0442805
28320690	318	325	testing	T169	C0039593
28320690	330	350	sexually transmitted	T047	C0036916
28320690	355	377	blood-borne infections	T169	C1636665
28320690	379	385	STBBIs	T047	C0012634
28320690	394	409	high-prevalence	T081	C1512456
28320690	410	421	populations	T098	C1257890
28320690	429	436	testing	T169	C0039593
28320690	451	459	increase	T169	C0442805
28320690	460	468	clinical	T073,T093	C0442592
28320690	469	472	STI	T047	C0036916
28320690	473	480	service	T057	C0557854
28320690	481	489	capacity	T081	C1516240
28320690	491	494	GCO	T170	C2349146
28320690	499	507	promoted	T052	C0033414
28320690	516	533	email invitations	T170	C0013849
28320690	537	547	provincial	T073,T093	C0020026
28320690	548	551	STI	T047	C0036916
28320690	552	558	clinic	T073,T093	C0442592
28320690	559	566	clients	T096	C0008942
28320690	568	574	access	T082	C0444454
28320690	584	591	clients	T096	C0008942
28320690	602	608	access	T082	C0444454
28320690	619	625	clinic	T073,T093	C0442592
28320690	633	640	testing	T169	C0039593
28320690	642	650	deferred	T079	C0205421
28320690	651	658	testers	T169	C0039593
28320690	667	675	campaign	T058	C0205787
28320690	679	682	gay	T098	C0242657
28320690	684	692	bisexual	T098	C0178515
28320690	704	729	men who have sex with men	T098	C2827413
28320690	731	734	MSM	T098	C2827413
28320690	741	750	objective	T170	C0018017
28320690	758	763	study	T062	C2603343
28320690	771	777	report	T058	C0700287
28320690	781	796	characteristics	T080	C1521970
28320690	800	803	GCO	T170	C2349146
28320690	804	809	users	T098	C1706077
28320690	811	814	use	T169	C0457083
28320690	819	832	test outcomes	T169	C1274040
28320690	849	869	promotional strategy	T052	C0033414
28320690	883	888	pilot	T080	C1517586
28320690	889	894	phase	T079	C0205390
28320690	899	903	used	T169	C0457083
28320690	904	907	GCO	T170	C2349146
28320690	908	915	program	T077	C1709697
28320690	916	920	data	T078	C1511726
28320690	922	929	website	T170	C2349146
28320690	943	953	provincial	T073,T093	C0020026
28320690	954	957	STI	T047	C0036916
28320690	958	964	clinic	T073,T093	C0442592
28320690	965	972	records	T170	C0025102
28320690	985	993	temporal	T079	C2362314
28320690	994	1000	trends	T079	C1521798
28320690	1002	1013	progression	T169	C0449258
28320690	1026	1033	service	T057	C0557854
28320690	1047	1058	demographic	T090	C0011298
28320690	1060	1064	risk	T078	C0035647
28320690	1070	1086	testing outcomes	T169	C1274040
28320690	1091	1102	individuals	T098	C0027361
28320690	1103	1111	creating	T052	C1706214
28320690	1112	1115	GCO	T170	C2349146
28320690	1145	1151	months	T079	C0439231
28320690	1155	1169	implementation	T052	C1708476
28320690	1178	1185	clients	T096	C0008942
28320690	1186	1194	creating	T052	C1706214
28320690	1217	1226	submitted	T169	C1515023
28320690	1227	1236	specimens	T167	C0370003
28320690	1257	1263	tested	T169	C0039593
28320690	1299	1307	positive	T033	C1446409
28320690	1308	1311	STI	T047	C0036916
28320690	1312	1321	diagnosis	T033	C0011900
28320690	1327	1337	proportion	T081	C1709707
28320690	1341	1348	clients	T096	C0008942
28320690	1349	1359	submitting	T169	C1515023
28320690	1360	1369	specimens	T167	C0370003
28320690	1370	1379	increased	T169	C0442805
28320690	1380	1388	steadily	T080	C0205361
28320690	1398	1404	course	T079	C0750729
28320690	1412	1417	pilot	T080	C1517586
28320690	1418	1423	phase	T079	C0205390
28320690	1434	1446	introduction	T169	C0579004
28320690	1450	1458	deferred	T079	C0205421
28320690	1459	1465	tester	T169	C0039593
28320690	1473	1480	Clients	T096	C0008942
28320690	1486	1493	diverse	T080	C1880371
28320690	1510	1513	age	T032	C0001779
28320690	1515	1521	gender	T032	C0079399
28320690	1527	1536	ethnicity	T080	C0243103
28320690	1547	1552	youth	T100	C0087178
28320690	1557	1568	individuals	T098	C0027361
28320690	1572	1590	nonwhite ethnicity	T080	C0243103
28320690	1596	1612	underrepresented	T080	C0205556
28320690	1625	1632	clients	T096	C0008942
28320690	1644	1648	risk	T078	C0035647
28320690	1644	1660	risk assessments	T058	C0086930
28320690	1679	1682	MSM	T098	C2827413
28320690	1700	1711	symptomatic	T169	C0231220
28320690	1728	1731	STI	T047	C0036916
28320690	1754	1762	reported	T058	C0700287
28320690	1763	1773	condomless	T033	C0243095
28320690	1774	1777	sex	T040	C0009253
28320690	1791	1799	reported	T058	C0700287
28320690	1803	1811	partners	T098	C0036911
28320690	1826	1832	months	T079	C0439231
28320690	1849	1857	reported	T058	C0700287
28320690	1860	1866	recent	T079	C0332185
28320690	1867	1870	STI	T047	C0036916
28320690	1874	1879	total	T080	C0439810
28320690	1894	1897	GCO	T170	C2349146
28320690	1898	1905	clients	T096	C0008942
28320690	1911	1918	testing	T169	C0039593
28320690	1956	1963	created	T052	C1706214
28320690	1985	1991	clinic	T073,T093	C0442592
28320690	1992	2003	invitations	T170	C2826348
28320690	2007	2016	diagnoses	T033	C0011900
28320690	2039	2047	deferred	T079	C0205421
28320690	2048	2055	testers	T169	C0039593
28320690	2059	2068	diagnoses	T033	C0011900
28320690	2091	2111	promotional campaign	T058	C0205787
28320690	2115	2124	diagnoses	T033	C0011900
28320690	2164	2173	diagnosis	T033	C0011900
28320690	2180	2190	evaluation	T058	C0220825
28320690	2205	2208	GCO	T170	C2349146
28320690	2215	2225	acceptable	T080	C1879533
28320690	2258	2269	individuals	T098	C0027361
28320690	2273	2280	testing	T169	C0039593
28320690	2300	2307	testers	T169	C0039593
28320690	2318	2321	use	T169	C0457083
28320690	2327	2330	STI	T047	C0036916
28320690	2331	2340	diagnosis	T033	C0011900
28320690	2344	2355	individuals	T098	C0027361
28320690	2366	2372	access	T082	C0444454
28320690	2383	2389	clinic	T073,T093	C0442592
28320690	2397	2404	testing	T169	C0039593
28320690	2413	2416	GCO	T170	C2349146
28320690	2442	2447	STBBI	T047	C0012634
28320690	2448	2455	testing	T169	C0039593
28320690	2468	2477	diagnosis	T033	C0011900
28320690	2486	2489	MSM	T098	C2827413
28320690	2494	2505	individuals	T098	C0027361
28320690	2506	2515	reporting	T058	C0700287
28320690	2516	2527	sexual risk	T078	C0035647
28320690	2528	2536	suggests	T078	C1705535
28320690	2537	2540	GCO	T170	C2349146
28320690	2551	2562	populations	T098	C1257890
28320690	2570	2576	higher	T080	C0205250
28320690	2577	2581	risk	T078	C0035647
28320690	2585	2588	STI	T047	C0036916
28320690	2590	2600	Motivation	T041	C0026605
28320690	2604	2608	test	T169	C0039593
28320690	2624	2630	access	T082	C0444454
28320690	2631	2639	clinical	T073,T093	C0442592
28320690	2640	2648	services	T057	C0557854
28320690	2676	2682	factor	T169	C1521761
28320690	2683	2693	underlying	T169	C1527178
28320690	2694	2697	GCO	T170	C2349146
28320690	2698	2701	use	T169	C0457083
28320690	2709	2717	findings	T169	C2607943
28320690	2755	2762	testing	T169	C0039593
28320690	2763	2768	model	T170	C3161035
28320690	2778	2787	promotion	T052	C0033414
28320690	2793	2799	future	T079	C0016884
28320690	2800	2808	research	T062	C0035168
28320690	2820	2833	understanding	T041	C0162340
28320690	2834	2841	reasons	T078	C0392360
28320690	2867	2874	service	T057	C0557854
28320690	2892	2905	comprehensive	T080	C1880156
28320690	2906	2916	evaluation	T058	C0220825
28320690	2920	2933	effectiveness	T080	C1280519
28320690	2936	2945	Increased	T169	C0442805
28320690	2957	2966	diagnosis	T033	C0011900
28320690	2957	2966	diagnosis	T033	C0011900
28320690	2986	2995	expansion	T082	C0205229
28320690	3003	3010	service	T057	C0557854
28320690	3018	3034	British Columbia	T083	C0006193
28320690	3040	3046	permit	T080	C0521104
28320690	3047	3053	future	T079	C0016884
28320690	3047	3053	future	T079	C0016884
28320690	3054	3064	evaluation	T058	C0220825
28320690	3073	3080	service	T057	C0557854
28320690	3096	3107	populations	T098	C1257890